Evidence map›Paper›PMID 19221203›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2009

Estrogen and mechanisms of vascular protection.

Dongqi Xing, Susan Nozell, Yiu-Fai Chen, Fadi Hage, Suzanne Oparil

Open access · bronzeAbstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 2 pooled it
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 2 syntheses or guidelines pooled it, 367 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dongqi XingVascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-0007, USA.
Susan Nozell
Yiu-Fai Chen
Fadi Hage
Suzanne Oparil
University of Alabama at Birmingham · US

Funding

MECHANISMS OF HYPERTENSION AND CARDIOVASCULAR DISEASEST32HL007457 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Martin E Young · 1985 to 2026
$8.6M
ATRIAL NATRIURETIC PEPTIDE IN PULMONARY HYPERTENSIONR01HL044195 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHEN, YIU-FAI · 1990 to 2010
$2.6M
O-GlyNAcylation: Novel Mechanism of Estrogen-Induced VasoprotectionR01HL087980 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OPARIL, SUZANNE · 2009 to 2012
$1.4M
ADVENTITIAL RESPONSE TO VASCULAR INJURY: ESTROGENR01HL064614 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OPARIL, SUZANNE · 2000 to 2003
$1.4M
ANP Modulates Cardiac Remodeling via Cardiac FibroblastsR01HL080017 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHEN, YIU-FAI · 2006 to 2009
$1.4M
Estrogen Modulates Injury-Induced InflammationR01HL075211 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OPARIL, SUZANNE · 2004 to 2007
$1.4M
NHLBI NIH HHS HL044195NHLBI NIH HHS HL07457NHLBI NIH HHS HL080017NHLBI NIH HHS HL087980NHLBI NIH HHS HL64614NHLBI NIH HHS HL75211NHLBI NIH HHS R01 HL044195NHLBI NIH HHS R01 HL064614NHLBI NIH HHS R01 HL075211NHLBI NIH HHS R01 HL080017NHLBI NIH HHS R01 HL087980NHLBI NIH HHS T32 HL007457
6 · The paper itself

Abstract

Estrogen has antiinflammatory and vasoprotective effects when administered to young women or experimental animals that appear to be converted to proinflammatory and vasotoxic effects in older subjects, particularly those that have been hormone free for long periods. Clinical studies have raised many important questions about the vascular effects of estrogen that cannot easily be answered in human subjects. Here we review cellular/molecular mechanisms by which estrogen modulates injury-induced inflammation, growth factor expression, and oxidative stress in arteries and isolated vascular smooth muscle cells, with emphasis on the role of estrogen receptors and the nuclear factor-kappaB (NFkappaB) signaling pathway, as well as evidence that these protective mechanisms are lost in aging subjects.

Indexed as

Women's HealthAge FactorsAgingAnimalsArteriesCardiovascular DiseasesChemokinesChemotaxis, LeukocyteCytokinesEstrogen Replacement TherapyEstrogensFemaleHumansInflammationIntercellular Signaling Peptides and ProteinsNF-kappa BChemokinesCytokinesEstrogensIntercellular Signaling Peptides and ProteinsNF-kappa BReceptors, Estrogen

Identifiers

PMID19221203
PMCPMC2700771
OpenAlexW2124138031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.